Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/12/2014US8802645 Molecule for treating an inflammatory disorder
08/12/2014US8802641 Method for inhibiting onset of or treating pollen allergy
08/12/2014US8802638 Flavonoid treatment of glycogen synthase kinase-based disease
08/12/2014US8802636 Combination therapy for treatment of sleep apnea
08/12/2014US8802631 Peptides and methods for the treatment of gliomas and other cancers
08/12/2014US8802623 PAR-1 antagonists for use in the treatment or prevention of influenza virus type A infections
08/12/2014US8802618 Controlled modulation of amino acid side chain length of peptide antigens
08/12/2014US8802433 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
08/12/2014US8802240 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
08/12/2014US8802179 Non-digestible sugar-coated products and process
08/12/2014US8802162 L-citrulline for treating endothelial dysfunction and erectile dysfunction
08/12/2014US8802149 Systems and processes for spray drying hydrophobic and hydrophilic components
08/12/2014US8802147 Controlled release of biologically active compounds
08/12/2014US8802145 Highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step
08/12/2014US8802142 Pharmaceutical compositions comprising levetiracetam and process for their preparation
08/12/2014US8802141 Agent delivery system
08/12/2014US8802140 Situ mixing and application of hydrocolloid systems for pre- and post harvest use on agricultural crops
08/12/2014US8802139 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
08/12/2014US8802138 Methods and compositions for improved deliver, expression or activity of RNA interference agents
08/12/2014US8802137 Sustained release of antiinfectives
08/12/2014US8802133 Silicone scar treatment preparation
08/12/2014US8802130 Sublingual buccal effervescent
08/12/2014US8802129 Methods for treating retinopathy with extended therapeutic effect
08/12/2014US8802128 Steroid-containing sustained release intraocular implants and related methods
08/12/2014US8802125 Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof
08/12/2014US8802123 Endosseous implant
08/12/2014US8802117 Melatonin and immunostimulating substance-based compositions
08/12/2014US8802105 Antibacterial compositions
08/12/2014US8802099 Methods to treat allergic conditions
08/12/2014US8802098 Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide
08/12/2014US8802087 Pharmaceutical compositions of lipase-containing products, in particular of pancreation
08/12/2014US8802083 Method of making platelet and poly-beta-1,4-N-acetylglucosamine fiber compositions
08/12/2014US8802074 Polymers functionalized with ion-specific recognition elements
08/12/2014US8802073 Methods and compositions for wound healing
08/12/2014US8802072 Biocompatible adhesive materials and methods
08/12/2014US8802061 Aqueous disinfectants and sterilants for skin and mucosal application
08/12/2014US8802055 Use of the spin crossover complex [mx+(LY)HW]AN)Z as a magnetic resonance imaging contrast agent
08/12/2014CA2807787C Hmb compositions and uses thereof
08/12/2014CA2805543A1 Porphyrin compounds and their use as mri contrast agents
08/12/2014CA2802535C Thioacetate compounds, compositions and methods of use
08/12/2014CA2755266C Intermediates for preparing macrocyclic analogs
08/12/2014CA2749235C Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
08/12/2014CA2739751C Pharmaceutical compositions comprising hydromorphone and naloxone
08/12/2014CA2726040C Quinazoline derivatives
08/12/2014CA2707648C Isoxazolo-pyridine derivatives
08/12/2014CA2684482C Stents having biodegradable layers
08/12/2014CA2683941C Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
08/12/2014CA2680433C Novel composition based on cholest-4-ene-3-one oxime
08/12/2014CA2668775C Melt-processed imatinib dosage form
08/12/2014CA2665924C Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
08/12/2014CA2656067C Treatment of vasomotor symptoms with selective estrogen receptor modulators
08/12/2014CA2652226C Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
08/12/2014CA2650423C Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol
08/12/2014CA2645638C Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
08/12/2014CA2642376C Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
08/12/2014CA2639904C Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same
08/12/2014CA2633186C 2-adamantylurea derivatives as selective 11.beta.-hsd1 inhibitors
08/12/2014CA2630935C Beta glycolipids as immuno-modulators
08/12/2014CA2630816C Pharmaceutical comprising ppar agonist
08/12/2014CA2629815C Integrin-binding small molecules
08/12/2014CA2629312C Compositions and methods for treating cns disorders
08/12/2014CA2623203C Methods for treating viral infections using polyamine analogs
08/12/2014CA2621310C Sulfonamide derivative having pgd2 receptor antagonistic activity
08/12/2014CA2592301C Use of antioxidants to promote oral health in companion animals
08/12/2014CA2589453C Pharmaceutical formulations
08/12/2014CA2585172C Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/12/2014CA2579732C Tablets with site time-controlled gastrointestinal release of active ingredient
08/12/2014CA2572223C Angiogenesis inhibitors
08/12/2014CA2559836C Thermogenic and fiber containing weight-loss supplement
08/12/2014CA2542327C Combination therapy for cancer
08/12/2014CA2540681C Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
08/12/2014CA2540038C Aerosol formulations comprising formoterol fumarate dihydrate, a propellant,ethanol and optionally a steroid,where the formoterol fumarate dihydrate has a water content of 4.8-4.28% by weight
08/12/2014CA2528545C Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
08/12/2014CA2527168C Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
08/12/2014CA2520225C Benzenesulfonamide derivatives
08/12/2014CA2509666C Methods and compositions using compounds from fetal cells and tissues to improve condition of skin
08/12/2014CA2501422C Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
08/12/2014CA2492047C Short duration depot formulations
08/12/2014CA2343223C Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/11/2014CA2842767A1 Compositions for improved body composition
08/07/2014WO2014121221A1 Administration of an anti-activin-a compound to a subject
08/07/2014WO2014121178A1 Smac mimetic method of treatment
08/07/2014WO2014121170A2 Antiviral compounds
08/07/2014WO2014121137A2 Compositions and methods for the treatment of neurodegenerative and other diseases
08/07/2014WO2014121124A1 Boron-containing small molecules as antiprotozoal agents
08/07/2014WO2014121064A1 Method for treating and curing leishmaniosis using fexinindazole
08/07/2014WO2014121062A1 Selective hdac3 inhibitors
08/07/2014WO2014121040A1 Flap modulators
08/07/2014WO2014121033A1 Soluble complexes of drug analogs and albumin
08/07/2014WO2014121028A1 Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
08/07/2014WO2014121027A1 Aqueous ophthalmic solutions of phentolamine and medical uses thereof
08/07/2014WO2014120995A2 Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity
08/07/2014WO2014120994A1 Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
08/07/2014WO2014120982A1 Solid dispersion formulation of an antiviral compound
08/07/2014WO2014120981A1 Combination formulation of two antiviral compounds
08/07/2014WO2014120936A2 Treatments for depression and other diseases with a low dose agent
08/07/2014WO2014120919A1 Methods for rejuvenating red blood cells
08/07/2014WO2014120885A1 Treatment of drug abuse by preventing gapdh nitrosylation
08/07/2014WO2014120820A1 Amides as modulators of sodium channels
08/07/2014WO2014120815A1 Quinoline and quinazoline amides as modulators of sodium channels
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 7860